Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brynja Ármannsdóttir"'
Autor:
Elias Eythorsson, Valgerdur Bjarnadottir, Hrafnhildur Linnet Runolfsdottir, Dadi Helgason, Ragnar Freyr Ingvarsson, Helgi K. Bjornsson, Lovisa Bjork Olafsdottir, Solveig Bjarnadottir, Arnar Snaer Agustsson, Kristin Oskarsdottir, Hrafn Hliddal Thorvaldsson, Gudrun Kristjansdottir, Aron Hjalti Bjornsson, Arna R. Emilsdottir, Brynja Armannsdottir, Olafur Gudlaugsson, Sif Hansdottir, Magnus Gottfredsson, Agnar Bjarnason, Martin I. Sigurdsson, Olafur S. Indridason, Runolfur Palsson
Publikováno v:
Diagnostic and Prognostic Research, Vol 6, Iss 1, Pp 1-10 (2022)
Abstract Background The severity of SARS-CoV-2 infection varies from asymptomatic state to severe respiratory failure and the clinical course is difficult to predict. The aim of the study was to develop a prognostic model to predict the severity of C
Externí odkaz:
https://doaj.org/article/76ca9c34d77a4aa092609836e3260bd1
Autor:
Belson Rugwizangoga, Maria E. Andersson, Jean-Claude Kabayiza, Malin S. Nilsson, Brynja Ármannsdóttir, Johan Aurelius, Staffan Nilsson, Kristoffer Hellstrand, Magnus Lindh, Anna Martner
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 9 (2019)
Polymorphisms in the interferon lambda gene locus (IFNL) such as the IFNL4 genetic variants rs12979860 and rs368234815 are predictive of resolution of hepatitis C virus infection, but information about the impact of these variants in other infections
Externí odkaz:
https://doaj.org/article/772c96687b554e0abbe535749e2fd851
Autor:
Siggeir F. Brynjolfsson, Hildur Sigurgrimsdottir, Elin D. Einarsdottir, Gudrun A. Bjornsdottir, Brynja Armannsdottir, Gudrun E. Baldvinsdottir, Agnar Bjarnason, Olafur Gudlaugsson, Sveinn Gudmundsson, Sigurveig T. Sigurdardottir, Arthur Love, Karl G. Kristinsson, Bjorn R. Ludviksson
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
A detailed understanding of the antibody response against SARS-CoV-2 is of high importance, especially with the emergence of novel vaccines. A multiplex-based assay, analyzing IgG, IgM, and IgA antibodies against the receptor binding domain (RBD), sp
Externí odkaz:
https://doaj.org/article/6625dfbf1c9d4b0aad920aeb197a2d53